| Trial ID: | L3390 |
| Source ID: | NCT02056366
|
| Associated Drug: |
Α-Lipoic Acid
|
| Title: |
The Effect of α-lipoic Acid Treatment in Patient With Cardiac Autonomic Neuropathy
|
| Acronym: |
CANON
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Cardiac Autonomic Neuropathy
|
| Interventions: |
DRUG: α-lipoic acid
|
| Outcome Measures: |
Primary: Primary Efficacy of α-lipoic Acid in patients with cardiac autonomic neuropathy, check the Heart rate variability(HRV) Index, up to 24weeks | Secondary: Secondary Efficacy of α-lipoic Acid in patients with cardiac autonomic neuropathy, Check the Autonomic Nerve System(ANS) function 5 test, up to 24weeks | Other: Number of Patients with Adverse events as a Measure of Safety, Check the Number of Adverse events, up to 24weeks
|
| Sponsor/Collaborators: |
Sponsor: The Catholic University of Korea
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
91
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-01
|
| Completion Date: |
2013-09
|
| Results First Posted: |
|
| Last Update Posted: |
2014-02-06
|
| Locations: |
The Catholic University of Korea, Seoul, 137-701, Korea, Republic of|Eulji General Hospital, Seoul, Korea, Republic of|Sejong General Hospital, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02056366
|
